MicroRNA-155 controls vincristine sensitivity and predicts superior clinical outcome in diffuse large B-cell lymphomaHanne Due, Karen Dybkær, Xiaohong Tan et al.|Blood Advances|2019Cited by 34
High CXCR4 expression impairs rituximab response and the prognosis of R-CHOP-treated diffuse large B-cell lymphoma patientsMaria Bach Laursen, Karen Dybkær, Linn Reinholdt et al.|Oncotarget|2019Cited by 28
Expression of NOTCH3 exon 16 differentiates Diffuse Large B-cell Lymphoma into molecular subtypes and is associated with prognosisDitte Starberg Jespersen, Karen Dybkær, Anna A. Schönherz et al.|Scientific Reports|2019Cited by 7
A multiple myeloma classification system that associates normal B-cell subset phenotypes with prognosisJulie Støve Bødker, Martin Bøgsted, Rasmus Froberg Brøndum et al.|Blood Advances|2018Cited by 6